Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enting

Showing results (201-210 of 232) with videos related to

Pageof 24
Sort By:
Neuro-Oncology Advances|February 22, 2021
Extent of radiological response does not reflect survival in primary central nervous system lymphomaMatthijs van der Meulen, Alida A Postma, Marion Smits, et al.
Journal of Neuro-Oncology|February 20, 2025
Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort studyHiska L van der Weide, Anne M Buunk, Femke F Siebenga, et al.
Neuro-Oncology|February 9, 2021
Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trialMatthijs van der Meulen, Linda Dirven, Esther J J Habets, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2015
TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PETMartha W den Hollander, Frederike Bensch, Andor W J M Glaudemans, et al.
Acta Neuropathologica|January 26, 2018
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033Pierre Bady, Sebastian Kurscheid, Mauro Delorenzi, et al.
Journal of Clinical Medicine|January 25, 2025
Assessing the Validity of Diffusion Weighted Imaging Models: A Study in Patients with Post-Surgical Lower-Grade GliomaAnouk van der Hoorn, Lesley E Manusiwa, Hiske L van der Weide, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|July 17, 2021
Designing a Pragmatic Intervention to Help Improve the Bladder Cancer Patient ExperienceAgustina Bessa, Cecilia Bosco, Fidelma Cahill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951Martin J van den Bent, Alba A Brandes, Martin J B Taphoorn, et al.
Clinical and Translational Radiation Oncology|February 24, 2022
Clinical relevance of the radiation dose bath in lower grade glioma, a cross-sectional pilot study on neurocognitive and radiological outcomeHiska L van der Weide, Justyna Kłos, Johannes A Langendijk, et al.
The Lancet. Oncology|October 1, 2016
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyJaap C Reijneveld, Martin J B Taphoorn, Corneel Coens, et al.
Pageof 24

Showing results (201-210 of 232) with videos related to

Sort By:
Pageof 24
Neuro-Oncology Advances|February 22, 2021
Extent of radiological response does not reflect survival in primary central nervous system lymphomaMatthijs van der Meulen, Alida A Postma, Marion Smits, et al.
Journal of Neuro-Oncology|February 20, 2025
Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort studyHiska L van der Weide, Anne M Buunk, Femke F Siebenga, et al.
Neuro-Oncology|February 9, 2021
Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trialMatthijs van der Meulen, Linda Dirven, Esther J J Habets, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2015
TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PETMartha W den Hollander, Frederike Bensch, Andor W J M Glaudemans, et al.
Acta Neuropathologica|January 26, 2018
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033Pierre Bady, Sebastian Kurscheid, Mauro Delorenzi, et al.
Journal of Clinical Medicine|January 25, 2025
Assessing the Validity of Diffusion Weighted Imaging Models: A Study in Patients with Post-Surgical Lower-Grade GliomaAnouk van der Hoorn, Lesley E Manusiwa, Hiske L van der Weide, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|July 17, 2021
Designing a Pragmatic Intervention to Help Improve the Bladder Cancer Patient ExperienceAgustina Bessa, Cecilia Bosco, Fidelma Cahill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951Martin J van den Bent, Alba A Brandes, Martin J B Taphoorn, et al.
Clinical and Translational Radiation Oncology|February 24, 2022
Clinical relevance of the radiation dose bath in lower grade glioma, a cross-sectional pilot study on neurocognitive and radiological outcomeHiska L van der Weide, Justyna Kłos, Johannes A Langendijk, et al.
The Lancet. Oncology|October 1, 2016
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyJaap C Reijneveld, Martin J B Taphoorn, Corneel Coens, et al.
Pageof 24